Skip to main content
. 2023 Jun 28;8(8):765–772. doi: 10.1001/jamacardio.2023.1749

Table 1. Baseline Characteristics of Study Patients.

Characteristic No. (%)
CPVI plus (n = 219) CPVI alone (n = 219)
Sex
Male 111 (50.7) 108 (49.3)
Female 108 (49.3) 111 (50.7)
Age, mean (SD), y 70.2 (4.7) 70.7 (4.1)
AF history, median (IQR), mo 24.0 (6.0-48.0) 14 (4.0-48.0)
BMI, mean (SD)a 24.3 (3.5) 24.6 (3.0)
<25 129 (62.6) 131 (60.6)
≥25 77 (37.4) 85 (39.4)
Comorbidities
Hypertension 130 (59.4) 142 (64.8)
Diabetes 32 (14.6) 43 (19.6)
CAD 52 (23.7) 51 (23.3)
Stroke or TIA 17 (7.8) 21 (9.6)
Congestive heart failure 2 (0.9) 1 (0.5)
COPD 4 (1.8) 3 (1.4)
OSAS 2 (0.9) 2 (0.9)
CHA2DS2-VASc score, mean (SD) 2.3 (0.8) 2.5 (1.0)
1 54 (24.7) 50 (22.8)
2 81 (37.0) 67 (30.6)
3 62 (28.3) 69 (31.5)
>3 22 (10.1) 33 (15.1)
LAD, mean (SD), mm 38.8 (5.4) 38.8 (5.4)
LVEF, mean (SD), % 62.4 (5.3) 62.4 (5.4)

Abbreviations: AF, atrial fibrillation; BMI, body mass index; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; CPVI, circumferential pulmonary vein isolation; LAD, left atrial diameter; LVEF, left ventricular ejection fraction; OSAS, obstructive sleep apnea syndrome; TIA, transient ischemic attack.

a

Calculated as weight in kilograms divided by height in meters squared.